FIELD: medicine.
SUBSTANCE: group of inventions relates to methods and compositions for treating viral infection. In order to inhibit viral polymerase nucleic acids, a subject is administered a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt or hydrate thereof. Group of inventions also relates to a method of treatment, inhibition and prevention of a viral infection.
EFFECT: group of inventions enables to inhibit viral RNA-polymerase with suppression of RNA synthesis.
84 cl, 15 ex, 14 dwg, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR INHIBITING POLYMERASE | 2011 |
|
RU2718690C2 |
| IMMUNOGENIC COMPOSITIONS COMPRISING SILICIFIED VIRUS AND METHODS OF USE | 2014 |
|
RU2676083C2 |
| COMPOSITIONS AND METHODS FOR INHIBITING VIRAL POLYMERASE | 2013 |
|
RU2654482C2 |
| ANTIVIRAL COMPOSITION | 2020 |
|
RU2740660C1 |
| ANTIVIRAL COMPOSITION | 2020 |
|
RU2740657C1 |
| HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS FOR USE AGAINST CANCER AND VIRAL INFECTIONS | 2015 |
|
RU2766087C2 |
| APPLICATION OF TYLVALOSIN AS ANTIVIRAL AGENT | 2007 |
|
RU2412710C2 |
| INACTIVATED CHIMERIC VACCINES AND RELATED METHODS OF APPLICATION | 2006 |
|
RU2436591C2 |
| USE OF 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES IN ANTIVIRAL THERAPY | 2021 |
|
RU2820287C1 |
| ANTIVIRAL COMPOSITION | 2020 |
|
RU2751108C1 |
